| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2050143 | B | Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA | Homo sapiens | 16 | cell-based format | Scientific Literature | ||
| 2. | ALA2050144 | B | Inhibition of VEGFR2 in human U251 cells pretreated for 60 mins measured after 1 hr by ELISA | Homo sapiens | 16 | cell-based format | Scientific Literature | ||
| 3. | ALA2050145 | B | Inhibition of PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA | Homo sapiens | 16 | cell-based format | Scientific Literature | ||
| 4. | ALA2050146 | B | Ratio of sunitinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 5. | ALA2050147 | B | Ratio of erlotinib IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 6. | ALA2050148 | B | Ratio of SU4312 IC50 to compound IC50 for PDGFRbeta in human SF539 cells pretreated for 60 mins measured after 1 hr by ELISA | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 7. | ALA2050149 | F | Antiproliferative activity against human A431 cells after 48 hrs by CYQUANT assay | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
| 8. | ALA2050150 | F | Antiangiogenic activity in VEGF/bFGF-stimulated chicken embryo after 48 hrs by CAM assay | Gallus gallus | 14 | assay format | Scientific Literature | ||
| 9. | ALA2050151 | F | Growth inhibition of human CCRF-CEM cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 10. | ALA2050152 | F | Growth inhibition of human HL-60(TB) cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 11. | ALA2050153 | F | Growth inhibition of human K562 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 12. | ALA2050154 | F | Growth inhibition of human MOLT4 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 13. | ALA2050155 | F | Growth inhibition of human RPMI8226 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA2050156 | F | Growth inhibition of human SR cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 15. | ALA2050157 | F | Growth inhibition of human A549 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA2050158 | F | Growth inhibition of human EKVX cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 17. | ALA2050159 | F | Growth inhibition of human HOP62 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 18. | ALA2050160 | F | Growth inhibition of human HOP92 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 19. | ALA2050161 | F | Growth inhibition of human NCI-H226 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 20. | ALA2050162 | F | Growth inhibition of human NCI-H23 cells | Homo sapiens | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!